-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SON-DP in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SON-DP in Metastatic Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SON-DP in Metastatic Breast Cancer Drug Details: Proteins are under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SON-DP in Metastatic Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SON-DP in Metastatic Pancreatic Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SON-DP in Metastatic Pancreatic Cancer Drug Details: Proteins are under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SON-DP in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SON-DP in Metastatic Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SON-DP in Metastatic Colorectal Cancer Drug Details: Proteins are under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SON-DP in Metastatic Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SON-DP in Metastatic Ovarian Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SON-DP in Metastatic Ovarian Cancer Drug Details: Proteins are under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DP-303c in Epithelial Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DP-303c in Epithelial Ovarian Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.DP-303c in Epithelial Ovarian Cancer Drug Details:DP-303c is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DP-303c in Adenocarcinoma Of The Gastroesophageal Junction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DP-303c in Adenocarcinoma Of The Gastroesophageal Junction report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.DP-303c in Adenocarcinoma Of The Gastroesophageal Junction Drug Details:DP-303c is...
-
Sector Analysis
National Hockey League (NHL) 2023-24 – Analyzing Sponsorship Deals, League and Brand/Partner Breakdown
National Hockey League (NHL) 2023-24 Report Overview The estimated annual sponsorship revenue of the National Hockey League (NHL) is $480.05 million for the 2023-2024 season. The league follows a standard seasonal format, whereby each team completes 82 regular season games, 41 at home and 41 away. The teams are divided into two conferences, the East and West; these are then split into two sub-divisions which make up the main basis of competition for all franchises. The National Hockey League (NHL) 2023-24...
-
Sector Analysis
ICC Mens Cricket World Cup, 2023 – Post Event Analysis
ICC Mens Cricket World Cup, 2023 Report Overview The ICC Mens Cricket World Cup, 2023 had an estimated annual sponsorship revenue of $93,475,000 in 2023. The sporting event witnessed Australia declared the winner and India the runner-up. The tournament attracted a record of 1.25 million spectators. Disney+ Hotstar broke a viewership record of 59 million for the Men’s World Cup Final. The ICC Mens Cricket World Cup, 2023 research report provides a comprehensive analysis of the sponsorship portfolio, deal value,...
-
Product Insights
Dangshan Biomass Power Plant
Dangshan Biomass Power Plant is a biopower project located in Anhui, China. The project is owned by China Everbright Environment Group Ltd and was developed by DP CleanTech China . The project came online in 2011. Empower your strategies with our Dangshan Biomass Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...